TWD 22.35
(-1.76%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -62.34 Million TWD | -15.98% |
2022 | -53.75 Million TWD | -17.85% |
2021 | -45.61 Million TWD | -5.54% |
2020 | -43.21 Million TWD | 40.07% |
2019 | -51.86 Million TWD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -36.6 Million TWD | -12.06% |
2023 Q4 | -32.66 Million TWD | -10.06% |
2023 Q2 | -29.67 Million TWD | -8.46% |
2023 FY | - TWD | -15.98% |
2022 FY | - TWD | -17.85% |
2022 Q4 | -27.36 Million TWD | 0.0% |
2021 FY | - TWD | -5.54% |
2020 FY | - TWD | 40.07% |
2019 FY | - TWD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 115.838% |
Level Biotechnology Inc. | 98.7 Million TWD | 163.16% |
Sagittarius Life Science Corp | -44.73 Million TWD | -39.344% |
NeoCore Technology Co., Ltd. | -72.11 Million TWD | 13.553% |
TaiMed Biologics Inc. | -25.23 Million TWD | -147.061% |
GlycoNex Incorporation | -126.82 Million TWD | 50.846% |
VBI | -6.97 Million TWD | -794.162% |
GeneReach Biotechnology Corp. | -143.69 Million TWD | 56.616% |
Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 385.837% |
Visgeneer Inc. | 973 Thousand TWD | 6507.091% |
Mycenax Biotech Inc. | -339.48 Million TWD | 81.636% |
Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 106.657% |
G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 162.443% |
Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 93.71% |
TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -3489.004% |
Enimmune corporation | -228.96 Million TWD | 72.772% |
TaiRx, Inc. | -208.64 Million TWD | 70.121% |
CHO Pharma, Inc. | -277.73 Million TWD | 77.553% |
EirGenix Inc. | -664.4 Million TWD | 90.617% |
BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 184.354% |
Sunny Pharmtech Inc. | 69.14 Million TWD | 190.162% |
Lin BioScience, Inc. | -1.07 Billion TWD | 94.181% |
BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 44.883% |
Feng Chi Biotech Corp. | 34.83 Million TWD | 278.945% |
Lukas Biomedical Inc. | -26.3 Million TWD | -137.038% |
RBC Bioscience Corporation | 36.54 Million TWD | 270.578% |
BiOptic Inc. | 65.03 Million TWD | 195.853% |
BRIM Biotechnology, Inc. | -682.46 Million TWD | 90.865% |
Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -88.878% |
Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -13.523% |
Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 114.379% |
Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -34.809% |
SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -251.692% |
Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 39.834% |
Neith Corporation | -33.61 Million TWD | -85.483% |
Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 22.144% |
NaviFUS Corp. | -55.79 Million TWD | -11.732% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -275.593% |
Sinew Pharma Inc. | -163.63 Million TWD | 61.901% |
Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -1.367% |
Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 132.401% |
Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 72.498% |
AP Biosciences Inc | -325.51 Million TWD | 80.848% |
Medigen Biotechnology Corp. | -1.04 Billion TWD | 94.032% |
3D Global Biotech Inc. | -35.84 Million TWD | -73.913% |
Pharmosa Biopharm Inc. | 29.13 Million TWD | 314.01% |
Intech Biopharm Corporation | -219.58 Million TWD | 71.61% |
Oneness Biotech Co., Ltd. | -674.22 Million TWD | 90.754% |
Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -38.687% |
TWi Biotechnology, Inc. | -160.85 Million TWD | 61.244% |
Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 109.51% |
TCI GENE Inc. | 25.98 Million TWD | 339.948% |
MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 43.653% |
Senhwa Biosciences, Inc. | -283.78 Million TWD | 78.032% |
Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 57.292% |
NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 550.116% |
PharmaEngine, Inc. | 347.3 Million TWD | 117.95% |
Savior Lifetec Corporation | 219.6 Million TWD | 128.388% |
TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 136.196% |
OBI Pharma, Inc. | -855.08 Million TWD | 92.709% |
Meribank Biotech Co., Ltd | -92.56 Million TWD | 32.65% |
Acepodia, Inc. | -764.51 Million TWD | 91.846% |
Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 86.45% |